ProfileGDS4459 / ENSG00000173728
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 22% 24% 17% 6% 33% 24% 26% 21% 25% 20% 21% 15% 20% 20% 24% 30% 14% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.4322
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.5824
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.7717
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.696
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.7633
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.4424
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.3426
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.0721
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.2825
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.0720
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.221
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.6415
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.0620
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.4220
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.1924
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.7830
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.0914